| Literature DB >> 19125579 |
Wen-Ting Zhang1, Jin-Lan Ruan, Peng-Fei Wu, Feng-Chao Jiang, Li-Na Zhang, Wei Fang, Xiang-Long Chen, Yue Wang, Bao-Shuai Cao, Gang-Ying Chen, Yi-Jing Zhu, Jun Gu, Jian-Guo Chen.
Abstract
A series of novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors were designed within 2-aminothiazole analogues (4-10) based on a constructed three-dimensional pharmacophore model. After synthesis, the inhibitory effect on PARP-1 activity and the cytoprotective action of these compounds were tested and evaluated. Among them, compounds 4-6 and 10 appeared to be potent PARP-1 inhibitors with IC(50) values less than 1 microM, which had been perfectly predicted by pharmacophore model. These compounds proved to be highly potent against cell injury induced by H(2)O(2) and oxygen-glucose deprivation (OGD) in PC12 cells. These novel 2-aminothiazole analogues are potentially applicable as neuroprotective agents for the treatment of neurological diseases.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19125579 DOI: 10.1021/jm800902t
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446